These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3917871)

  • 1. Influence of isopropylvaleramide and allylisopropylacetamide on transformation of C3H/10T1/2 cells induced by benzo[a]pyrene derivatives.
    Krolewski B; Little JB
    Carcinogenesis; 1985 Jan; 6(1):7-11. PubMed ID: 3917871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of benzo(a)pyrene-induced transformation of C3H/10T1/2 cells by allylisopropylacetamide and isopropylvaleramide.
    Kuszynski C; Somogyi A; Nesnow S; Langenbach R
    Cancer Res; 1981 May; 41(5):1893-7. PubMed ID: 6260354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of aliphatic amides on oncogenic transformation, sister chromatid exchanges, and mutations induced by cyclopenta[cd]-pyrene and benzo[a]pyrene.
    Krolewski B; Nagasawa H; Little JB
    Carcinogenesis; 1986 Oct; 7(10):1647-50. PubMed ID: 3093110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione depletion suppresses conjugation of benzo[a]pyrene metabolites and (+/-)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene metabolites with glutathione but does not affect their binding to DNA in C3H/10T1/2 mouse fibroblasts.
    Hesse S; Krupski-Brennstuhl G; Cumpelik O; Mezger M; Wiebel FJ
    Carcinogenesis; 1987 Aug; 8(8):1051-8. PubMed ID: 3608089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of cytotoxicity, mutation, cytogenetic changes, and neoplastic transformation by benzo(a)pyrene and derivatives in C3H/10T1/2 clone 8 mouse fibroblasts.
    Gehly EB; Landolph JR; Heidelberger C; Nagasawa H; Little JB
    Cancer Res; 1982 May; 42(5):1866-75. PubMed ID: 6279286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of 3-hydroxybenzo(a)pyrene on the mutagenicity and tumorigenicity of (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene.
    Huang MT; Wood AW; Chang RL; Yagi H; Sayer JM; Jerina DM; Conney AH
    Cancer Res; 1986 Feb; 46(2):558-66. PubMed ID: 3079665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzo[alpha]pyrene diol epoxide I binds to DNA at replication forks.
    Paules RS; Cordeiro-Stone M; Mass MJ; Poirier MC; Yuspa SH; Kaufman DG
    Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2176-80. PubMed ID: 3127827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrasting disposition and metabolism of topically applied benzo(a)pyrene, trans-7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene, and 7 beta,8 alpha-dihydroxy-9 alpha,10 alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene in mouse epidermis in vivo.
    Melikian AA; Bagheri K; Hecht SS
    Cancer Res; 1987 Oct; 47(20):5354-60. PubMed ID: 3115566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin endoperoxide synthetase-dependent cooxidation of (+/-)-trans-7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene in C3H/10T 1/2 clone 8 cells.
    Boyd JA; Barrett JC; Eling TE
    Cancer Res; 1982 Jul; 42(7):2628-32. PubMed ID: 6805944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ellagic acid and hydroxylated flavonoids on the tumorigenicity of benzo[a]pyrene and (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene on mouse skin and in the newborn mouse.
    Chang RL; Huang MT; Wood AW; Wong CQ; Newmark HL; Yagi H; Sayer JM; Jerina DM; Conney AH
    Carcinogenesis; 1985 Aug; 6(8):1127-33. PubMed ID: 3926336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lack of transformation activity of 9-hydroxybenzo[a]pyrene related to the absence of modified deoxyribonucleosides in DNA of C3H/10T1/2 cells.
    Sala M; Rojas M; Alexandrov K
    Carcinogenesis; 1984 Aug; 5(8):1101-3. PubMed ID: 6547646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of individual human cytochrome P-450 enzymes in the bioactivation of benzo(a)pyrene, 7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene, and other dihydrodiol derivatives of polycyclic aromatic hydrocarbons.
    Shimada T; Martin MV; Pruess-Schwartz D; Marnett LJ; Guengerich FP
    Cancer Res; 1989 Nov; 49(22):6304-12. PubMed ID: 2509067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of glutathione levels in C3H/10T1/2 cells and its relationship to benzo(a)pyrene anti-7,8-dihydrodiol 9,10-epoxide-induced cytotoxicity.
    Ho D; Fahl WE
    J Biol Chem; 1984 Sep; 259(18):11231-5. PubMed ID: 6432794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA adduct formation in mouse tissues in relation to serum levels of benzo(a)pyrene-diol-epoxide after injection of benzo(a)pyrene or the diol-epoxide.
    Ginsberg GL; Atherholt TB
    Cancer Res; 1990 Feb; 50(4):1189-94. PubMed ID: 2105163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the intercalative binding of non-reactive benzo[a]pyrene metabolites and metabolite model compounds to DNA.
    Abramovich M; Prakash AS; Harvey RG; Zegar IS; Lebreton PR
    Chem Biol Interact; 1985 Oct; 55(1-2):39-62. PubMed ID: 3933843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the genotoxic activities of the K-region dihydrodiol of benzo[a]pyrene with benzo[a]pyrene in mammalian cells: morphological cell transformation; DNA damage; and stable covalent DNA adducts.
    Nesnow S; Davis C; Nelson GB; Lambert G; Padgett W; Pimentel M; Tennant AH; Kligerman AD; Ross JA
    Mutat Res; 2002 Nov; 521(1-2):91-102. PubMed ID: 12438007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic activation of benzo[a]pyrene-7,8-dihydrodiol and benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide to protein-binding products and the inhibitory effect of glutathione and cysteine.
    Jernström B; Dock L; Martinez M
    Carcinogenesis; 1984 Feb; 5(2):199-204. PubMed ID: 6421502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of the thymidine kinase gene after in vitro modification with benzo(a)pyrene-diol-epoxide and transfer to LTK- cells as a eukaryotic test for carcinogens.
    Schaefer-Ridder M; Moeroey T; Engelhardt U
    Cancer Res; 1984 Dec; 44(12 Pt 1):5861-6. PubMed ID: 6437673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumorigenicity studies with diol-epoxides of benzo(a)pyrene which indicate that (+/-)-trans-7beta,8alpha-dihydroxy-9alpha,10alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene is an ultimate carcinogen in newborn mice.
    Kapitulnik J; Wislocki PG; Levin W; Yagi H; Jerina DM; Conney AH
    Cancer Res; 1978 Feb; 38(2):354-8. PubMed ID: 620406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative significance of glutathione and glutathione-S-transferase in regulating benzo[a]pyrene anti diol-epoxide level in reconstituted C3H/10T1/2 cell lysates, and comparison to rat liver.
    Ho D; Fahl WE
    Carcinogenesis; 1984 Feb; 5(2):143-8. PubMed ID: 6321048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.